JP2023542945A5 - - Google Patents
Info
- Publication number
- JP2023542945A5 JP2023542945A5 JP2023518358A JP2023518358A JP2023542945A5 JP 2023542945 A5 JP2023542945 A5 JP 2023542945A5 JP 2023518358 A JP2023518358 A JP 2023518358A JP 2023518358 A JP2023518358 A JP 2023518358A JP 2023542945 A5 JP2023542945 A5 JP 2023542945A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- optionally substituted
- compound according
- accordance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082090P | 2020-09-23 | 2020-09-23 | |
| US63/082,090 | 2020-09-23 | ||
| PCT/US2021/051403 WO2022066678A1 (en) | 2020-09-23 | 2021-09-22 | Tes-based cationic lipids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542945A JP2023542945A (ja) | 2023-10-12 |
| JP2023542945A5 true JP2023542945A5 (https=) | 2024-10-01 |
| JP7844452B2 JP7844452B2 (ja) | 2026-04-13 |
Family
ID=78179524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518358A Active JP7844452B2 (ja) | 2020-09-23 | 2021-09-22 | Ｔｅｓベースのカチオン性脂質 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230357140A1 (https=) |
| EP (1) | EP4217340A1 (https=) |
| JP (1) | JP7844452B2 (https=) |
| KR (1) | KR20230092914A (https=) |
| CN (1) | CN116507606B (https=) |
| AU (1) | AU2021347814A1 (https=) |
| BR (1) | BR112023005269A2 (https=) |
| CA (1) | CA3193340A1 (https=) |
| IL (1) | IL301540A (https=) |
| MX (1) | MX2023003345A (https=) |
| WO (1) | WO2022066678A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4637813A1 (en) | 2022-12-20 | 2025-10-29 | Sanofi Pasteur | Rhinovirus mrna vaccine |
| CN117986153A (zh) * | 2023-09-07 | 2024-05-07 | 晟迪生物医药(苏州)有限公司 | 一种可电离阳离子脂质化合物及其制备方法和应用 |
| WO2026008743A1 (en) | 2024-07-02 | 2026-01-08 | Sanofi Pasteur Inc. | Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid |
| WO2026052114A1 (zh) * | 2024-09-09 | 2026-03-12 | 北京科兴中维生物技术有限公司 | 脂质纳米颗粒及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| CA2064783C (en) * | 1989-08-29 | 2002-12-17 | Richard C. Franson | Cytoprotective fatty moiety compounds |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| US7504506B2 (en) * | 2003-11-04 | 2009-03-17 | Elixir Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
| US20100055168A1 (en) * | 2008-04-16 | 2010-03-04 | Abbott Laboratories | Cationic lipids and uses thereof |
| KR101766408B1 (ko) | 2009-06-10 | 2017-08-10 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| EP3083556B1 (en) * | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| CN109414408B (zh) * | 2016-05-16 | 2022-03-29 | 得克萨斯州大学系统董事会 | 阳离子磺酰胺氨基脂质和两亲性两性离子氨基脂质 |
| GB201614120D0 (en) * | 2016-08-18 | 2016-10-05 | Univ Of Kwazulu-Natal | pH-responsive lipids |
| AU2017357758B2 (en) | 2016-11-10 | 2023-11-16 | Translate Bio, Inc. | Improved process of preparing mRNA-loaded lipid nanoparticles |
| US12479791B2 (en) * | 2018-08-10 | 2025-11-25 | Takeda Pharmaceutical Company Limited | Cationic lipid |
| WO2021226468A1 (en) * | 2020-05-07 | 2021-11-11 | Translate Bio, Inc. | Improved compositions for cftr mrna therapy |
| EP4146680A1 (en) * | 2020-05-07 | 2023-03-15 | Translate Bio, Inc. | Composition and methods for treatment of primary ciliary dyskinesia |
-
2021
- 2021-09-22 WO PCT/US2021/051403 patent/WO2022066678A1/en not_active Ceased
- 2021-09-22 KR KR1020237013612A patent/KR20230092914A/ko active Pending
- 2021-09-22 US US18/246,261 patent/US20230357140A1/en active Pending
- 2021-09-22 CA CA3193340A patent/CA3193340A1/en active Pending
- 2021-09-22 IL IL301540A patent/IL301540A/en unknown
- 2021-09-22 BR BR112023005269A patent/BR112023005269A2/pt unknown
- 2021-09-22 JP JP2023518358A patent/JP7844452B2/ja active Active
- 2021-09-22 MX MX2023003345A patent/MX2023003345A/es unknown
- 2021-09-22 EP EP21791537.0A patent/EP4217340A1/en active Pending
- 2021-09-22 AU AU2021347814A patent/AU2021347814A1/en not_active Abandoned
- 2021-09-22 CN CN202180075717.0A patent/CN116507606B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542945A5 (https=) | ||
| JP2023542944A5 (https=) | ||
| JP2023527575A5 (https=) | ||
| JP2023520047A5 (https=) | ||
| JP2023551058A5 (https=) | ||
| JP2005516067A5 (https=) | ||
| JP2022520061A5 (https=) | ||
| JP2005525322A5 (https=) | ||
| JP2001247459A5 (https=) | ||
| JP2001525359A5 (https=) | ||
| JP2006507265A5 (https=) | ||
| JP2002539128A5 (https=) | ||
| JP2005525323A5 (https=) | ||
| JP2017538677A5 (https=) | ||
| JP2024546431A5 (https=) | ||
| JP2006151984A5 (https=) | ||
| RU2003101319A (ru) | Фармацевтическая композиция, обладающая улучшенным противоопухолевым действием и/или сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты | |
| JP2019515908A5 (https=) | ||
| CN111012914A (zh) | 治疗肺部疾病的高穿透力前药组合物和医药组合物 | |
| JP2025509507A5 (https=) | ||
| JP2004500355A5 (https=) | ||
| JP2020505354A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2006525368A5 (https=) | ||
| RU2003131970A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств |